BARNETTE K GARY 4

What Happened

• K. Gary Barnette, Chief Scientific Officer of VERU, was granted a derivative award for 160,000 shares on May 4, 2026. The Form 4 reports an acquisition at $0.00 per share (derivative award), meaning no cash was paid by the insider in relation to this grant. This was an award/grant (not a market purchase or sale).

Key Details

• Transaction date: May 4, 2026; Form 4 filed May 6, 2026 (appears timely).
• Transaction type/code: Grant / award (derivative) — reported as “A”.
• Shares/units granted: 160,000; reported price: $0.00.
• Vesting: Footnote states options for one‑third of the shares vest on each of May 4, 2027; May 4, 2028; and May 4, 2029.
• Shares owned after transaction: Not disclosed in the provided filing summary.
• No sale/10b5‑1 or tax‑withholding noted in the provided details.

Context

• The filing describes a derivative grant (the footnote specifically references “options”), which typically vests over time and is used for retention/incentive purposes; it is not an immediate market purchase or sale and does not signal an immediate change in the insider’s market exposure. For full terms (exercise price, expiration, and plan details), check the complete Form 4 and the company’s related disclosures.